EQH Stock Analysis: Axa Equitable Holdings | NYSE
Asset Management | NYSE, USA | Market Cap: 11.977m USD | 12M Return: -16% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 169M
EPS Trend: 82.3%
Qual. Beats: 0
Rev. Trend: 56.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 8.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Equitable Holdings, Inc. (EQH) is a diversified financial services company headquartered in New York, operating through six business segments: Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. The company primarily serves affluent and high-net-worth individuals through variable annuity products, while also providing retirement services to plans sponsored by educational entities, municipalities, non-profit organizations, and small-to-medium-sized businesses. Its offerings span investment management, life insurance (including VUL, COLI, IUL, and term life), employee benefits, and advisory/financial planning services, with the Legacy segment housing its capital-intensive fixed-rate GMxB business. The company was founded in 1859, was formerly known as AXA Equitable Holdings, Inc., and adopted its current name in January 2020.
As a large-cap U.S. financials company listed on the NYSE, EQH operates within the diversified financial services sub-industry, generating revenue through a mix of insurance premiums, asset-based fees, and advisory commissions. Variable annuities, a core product for the firm, are hybrid insurance-investment contracts that have faced increased regulatory scrutiny in recent years regarding living and death benefit guarantees.
- Interest rate path drives spread income and hedging costs
- Equity market gains lift Asset Management AUM and fees
- Legacy GMxB runoff releases capital for shareholder returns
| Net Income: -822.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.54 > 1.0 |
| NWC/Revenue: -536.6% < 20% (prev -450.7%; Δ -85.90% < -1%) |
| CFO/TA 0.00 > 3% & CFO 840.0m > Net Income -822.0m |
| Net Debt (-43.4b) to EBITDA (634.0m): -68.53 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (283.8m) vs 12m ago -9.01% < -2% |
| Gross Margin: 63.55% > 18% (prev 68.85%; Δ -5.30% > 0.5%) |
| Asset Turnover: 3.79% > 50% (prev 4.87%; Δ -1.09% > 0%) |
| Interest Coverage Ratio: -1.08 > 6 (EBIT TTM -249.0m / Interest Expense TTM 231.0m) |
| A: -0.20 (Total Current Assets 76.2b - Total Current Liabilities 137b) / Total Assets 310b |
| B: 0.03 (Retained Earnings 8.78b / Total Assets 310b) |
| C: -0.00 (EBIT TTM -249.0m / Avg Total Assets 299b) |
| D: 0.00 (Book Value of Equity 273.0m / Total Liabilities 308b) |
| Altman-Z'' = -1.20 = CCC |
| DSRI: 2.80 (Receivables 25.2b/11.1b, Revenue 11.3b/14.0b) |
| GMI: 1.08 (GM 68.85% / 63.55%) |
| AQI: 0.93 (AQ_t 0.75 / AQ_t-1 0.81) |
| SGI: 0.81 (Revenue 11.3b / 14.0b) |
| TATA: -0.01 (NI -822.0m - CFO 840.0m) / TA 310b) |
| Beneish M = -1.65 (Cap -4..+1) = CCC |
As of July 05, 2026, the stock is trading at USD 45.61 with a total of 3,191,060 shares traded. Over the past week, the price has changed by +4.04%, over one month by +14.45%, over three months by +19.49% and over the past year by -15.96%.
Current recommended Stop Loss: 43.80 (which is 4% or 1.5 ATR below the current price).
Axa Equitable Holdings has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy EQH.
- StrongBuy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 58.4 | 28.1% |
P/E Forward = 4.5851
P/S = 1.0577
P/B = 164.1395
Revenue TTM = 11.3b USD
EBIT TTM = -249.0m USD
EBITDA TTM = 634.0m USD
Long Term Debt = 6.93b USD (from longTermDebt, last quarter)
Short Term Debt = 25.0m USD (from shortTermDebt, last fiscal year)
Debt = 6.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -43.4b USD (calculated: Debt 6.93b - CCE 50.4b)
Enterprise Value = 12.0b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = -1.08 (Ebit TTM -249.0m / Interest Expense TTM 231.0m)
EV/FCF = 14.84x (Enterprise Value 12.0b / FCF TTM 807.0m)
FCF Yield = 6.74% (FCF TTM 807.0m / Enterprise Value 12.0b)
FCF Margin = 7.13% (FCF TTM 807.0m / Revenue TTM 11.3b)
Net Margin = -7.26% (Net Income TTM -822.0m / Revenue TTM 11.3b)
Gross Margin = 63.55% ((Revenue TTM 11.3b - Cost of Revenue TTM 4.13b) / Revenue TTM)
Gross Margin QoQ = 90.69% (prev 88.07%)
Tobins Q-Ratio = 0.04 (Enterprise Value 12.0b / Total Assets 310b)
Interest Expense / Debt = 3.33% (Interest Expense 231.0m / Debt 6.93b)
Taxrate = 17.59% (156.0m / 887.0m)
NOPAT = -205.2m (EBIT -249.0m * (1 - 17.59%)) [loss with tax shield]
Current Ratio = 0.56 (Total Current Assets 76.2b / Total Current Liabilities 137b)
Debt / Equity = 25.37 (Debt 6.93b / totalStockholderEquity, last quarter 273.0m)
Debt / EBITDA = -68.53 (Net Debt -43.4b / EBITDA 634.0m)
Debt / FCF = -53.84 (Net Debt -43.4b / FCF TTM 807.0m)
Total Stockholder Equity = 374.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.28% (Net Income -822.0m / Total Assets 310b)
RoE = -219.8% (Net Income TTM -822.0m / Total Stockholder Equity 374.0m)
RoCE = -3.41% (EBIT -249.0m / Capital Employed (Equity 374.0m + L.T.Debt 6.93b))
RoIC = -0.12% (negative operating profit) (NOPAT -205.2m / Invested Capital 173b)
WACC = 7.61% (E(12.0b)/V(18.9b) * Re(10.42%) + D(6.93b)/V(18.9b) * Rd(3.33%) * (1-Tc(0.18)))
Discount Rate = 10.42% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -7.38%
[DCF] Terminal Value 73.10% ; FCFF base≈1.41b ; Y1≈1.23b ; Y5≈996.3m
[DCF] Fair Price = 217.8 (EV 16.0b - Net Debt -43.4b = Equity 59.4b / Shares 273.0m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.33 | EPS CAGR: 10.39% | SUE: 0.09 | # QB: 0
Revenue Correlation: 56.68 | Revenue CAGR: 6.80% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.68 | Chg30d=+0.20% | Revisions=-55% | Analysts=12
EPS next Quarter (2026-09-30): EPS=1.83 | Chg30d=+0.56% | Revisions=-18% | Analysts=11
EPS current Year (2026-12-31): EPS=7.08 | Chg30d=+0.28% | Revisions=-44% | GrowthEPS=+25.5% | GrowthRev=+35.1%
EPS next Year (2027-12-31): EPS=8.81 | Chg30d=+0.23% | Revisions=-31% | GrowthEPS=+24.5% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: -44% (up=11, down=31)